Momentum Bonitas Deal Lifts Market Share To 30%

Learn about the Momentum Bonitas Deal and its impact on South Africa's medical scheme market, raising Momentum's share to 30%.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

8 October 2026

Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.

8 October 2026

Hospitals are investing in infection prevention and control as antimicrobial resistance rises, but experts say gaps remain.

8 October 2026

Experts say South Africa should track medicine shortages by whether patients get full treatment on time, not by stock figures alone.